Evaluation of muscle diseases using artificial neural network analysis of 31P MR spectroscopy data
- 1 November 1995
- journal article
- other
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 34 (5) , 664-672
- https://doi.org/10.1002/mrm.1910340504
Abstract
Dermatomyositis is an autoimmune disease characterized by an erythematous rash and severe muscle weakness. 31P Magnetic resonance spectroscopy (MRS) provides quantitative data for longitudinal monitoring of disease status and responses to immunosuppressive therapy. A disease variant, amyopathic dermatomyositis, presents with a typical rash but no clinical muscle weakness. However, metabolic abnormalities in the oxidative capacity of muscles of amyopathic patients during exercise were detected with 31P MRS. Because MRS provided the best quantitative data for evaluating dermatomyositis, the 31P metabolic parameters derived from the MR spectra were further processed using an artificial neural network (XERION). The neural network analyses provided additional clinical information from the weighted correlations of multiple 31P parameters, namely, inorganic phosphate, phos-phocreatine, ATP, phosphodiesters, and selected ratios. This investigation analyzes the relative importance of the various metabolic parameters for accurate patient characterization and provides insights into the pathogenesis of the disease.Keywords
This publication has 17 references indexed in Scilit:
- Use of magnetic resonance imaging and p-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositisArthritis & Rheumatism, 1995
- Magnetic resonance imaging and p‐31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositisArthritis & Rheumatism, 1994
- Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: Dermatomyositis sine myositis?Journal of the American Academy of Dermatology, 1993
- ReplyJournal of the American Academy of Dermatology, 1992
- P‐31 Magnetic Resonance Spectroscopy in Polymyositis and DermatomyositisArthritis & Rheumatism, 1992
- Serial magnetic resonance imaging in juvenile dermatomyositisArthritis & Rheumatism, 1991
- Polymyositis, Dermatomyositis, and Inclusion-Body MyositisNew England Journal of Medicine, 1991
- Magnetic resonance spectroscopy of normal and diseased musclesAmerican Journal of Medical Genetics, 1986
- Dermatomyositis without creatine kinase elevation. A poor prognostic signThe American Journal of Medicine, 1986
- Editorial BoardExperimental pathology, 1985